EFS
Essex Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-410
| Closed | -$260K | – | 704 |
|
|
2025
Q1 | $260K | Buy |
410
+78
| +23% | +$49.5K | 0.02% | 531 |
|
|
2024
Q4 | $237K | Buy |
332
+29
| +10% | +$20.7K | 0.02% | 553 |
|
|
2024
Q3 | $292K | Sell |
303
-40
| -12% | -$38.5K | 0.02% | 504 |
|
|
2024
Q2 | $382K | Buy |
343
+83
| +32% | +$92.4K | 0.03% | 430 |
|
|
2024
Q1 | $250K | Buy |
+260
| New | +$250K | 0.02% | 456 |
|